Intralesional Cidofovir Injections for Recurrent Laryngeal Papillomatosis: First Results;Intraläsionale Cidofovir-Injektion bei rezidivierender Larynxpapillomatose - Erste Ergebnisse

Laryngo- Rhino- Otologie

Volumn 82, Issue 10, 2003, Pages 700-706

  Neumann, Kerstin ^a   Pudszuhn, A ^a   Welzel, C ^a   Bartel Friedrich, S ^a   Passmann, M ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cidofovir; Larynx; Laser; Papillomatosis

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOSINE; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; CHILD; CLINICAL ARTICLE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG EFFICACY; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; LARYNX; LARYNX PAPILLOMATOSIS; LARYNX TUMOR; LASER SURGERY; MALE; MULTIMODALITY CANCER THERAPY; PAPILLOMA; PATHOLOGY; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT OUTCOME; TUMOR RECURRENCE; ULTRASTRUCTURE; VIRUS INCLUSION; WART VIRUS;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ANTIVIRAL AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYTOSINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCLUSION BODIES, VIRAL; INJECTIONS, INTRALESIONAL; LARYNGEAL NEOPLASMS; LARYNX; LASER SURGERY; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPHOSPHORUS COMPOUNDS; PAPILLOMA; PHOSPHONIC ACIDS; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0242323549     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43241     Document Type: Article

References (24)

1. Shah KV, Stern WF, Shah FK, Bishai D, Kashima HK. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J 1998; 17: 372-376
2. Derkay CS. Recurrent respiratory papillomatosis. Laryngoscope 2001; 111: 57-69
3. Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 1999; 125: 1143-1148
4. Derkay CS. Task force on recurrent respiratory papillomas. Arch Otolaryngol Head Neck Surg 1995; 121: 1386-1391
5. Rehberg E, Kleinsasser O. Malignant transformation in non-irradiated juvenile laryngeal papillomatosis. Eur Arch Otorhinolaryngol 1999; 256: 450-454
6. Snoeck R, Andrei G, De Clerq E. Cidofovir in the treatment of HPV-associated lesions. Verh K Acad Geneeskd Belg 2001; 63: 93-120
7. Produktmonographie Vistide Cidofovir. Erlangen: Pharmacia and Up-john GmbH, 1997: 45
8. Zabawski EJ. A review of topical and intralesional Cidofovir. Dermatology Online Journal 2000; 6: 3
9. Snoeck R, Noel JC, Muller C, De Clerq E, Bossens M. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III). J Med Virol 2000; 60: 205-209
10. Bielamowicz S, Villagomez V, Stage SV, Wilson WR. Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort. Laryngoscope 2002; 112: 696-699
11. Pransky SM, Brewster DF, Magit AE, Kearns DB. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000; 126: 1239-1243
12. Snoeck R, Wellens W, Desloovere C, VanRanst M, Naesens L, De Clerq E, Feenstra L. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine]. J Med Virol 1998; 54: 219-225
13. Lindeberg H, Elbrond O. Laryngeal papillomas: the epidemiology in a Danish subpopulation: 1965-1984. Clin Otolaryngol 1991; 15: 125-131
14. 2 Laser treatment in 244 patients with respiratory papillomas. Laryngoscope 2001; 111: 1639-1644
15. Bennett RS, Powell KR. Human papillomavirus: association between laryngeal papillomas and genital warts. Infect Dis J 1987; 6: 229-232
16. Cole RR, Myer CM, Cotton RT. Tracheotomy in children with recurrent papillomatosis. Head Neck 1989; 11: 226-230
17. Armstrong L, Derkay CS, Reeves WC, Task Force RRP. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 1999; 125: 743-748
18. Wilson WR, Hashemiyoon R, Hawrych A. Intralesional cidofovir for recurrent laryngeal papillomas: preliminary report. Ear Nose Throat J 2000; 79: 236-238, 240
19. Boltezar IH, Zargi M. Laryngeal papillomatosis. ZDRAV VESTN 2002; 71 (Suppl. III): 73-76
20. Van Cutsem E, Snoeck R, Van Ranst M, Fiten P, Opdenakker G, Geboes K, Janssens J, Rutgeerts P, Antrappen G, De Clerq E. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J Med Virol 1995; 45: 230-235
21. Lea AP, Bryson HM. Cidofovir. Drugs 1996; 52: 225-231
22. Cundy J. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin pharmacokinet 1999; 36: 127-143
23. Coulombeau B, Nusa NA, Ceruse P, Froehlich P. Rev Laryngol Otol Rhinol 2002; 123: 315-320
24. Cheville F. Ultrastructural Pathology. Iowa State University Press/Ames, 1994: 520